Stockholm, Sweden Saturday, February 22, 2025, 09:00 Hrs [IST] ...
54m
If you purchased or acquired securities in GSK between February 5, 2020 and August 14, 2022 and would like to discuss your ...
Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) ("Iovance" or the “Company”), a biotechnology company focused on innovating, developing, and delivering novel polyclonal tumor infiltrating lymphocyte ...
The cell and gene therapies in rare disorders market is expected to grow at a significantly high rate during the forecast period (2025–2034) and main ...
Tremfya was administered subcutaneously for both induction and maintenance, inducing a clinical response in 65% of moderate ...
Approved, Seladelpar Can Provide an Important Treatment Option for People Living With the Rare Liver Disease in the European Economic Area – ...
Pharmaceutical Excipients Market Competitive Research and Growth Analysis by Function (Pharmaceutical Fillers, Binders, Coatings, Disintegrants, Preservatives, Others), Application (Oral, Parenteral, ...
Copyright © 2025 BBC. The BBC is not responsible for the content of external sites. Read about our approach to external linking.
Copyright © 2025 BBC. The BBC is not responsible for the content of external sites. Read about our approach to external linking.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback